Osel Devices

SMENSE: OSELDEVICE
Compare with peers
₹ 340.60▲ 4.2 (+1.25%)28 Oct, 03:29 pm IST
Market cap
₹ 605 Cr.
P/E
20.7x
P/B
2.88x
52-week range
320 – 835
ROE
20%
ROCE
24%
Dividend yield
0%
Debt / equity
0.47
Sector
Healthcare Equipment & Supplies
Industry
Medical Equipment & Supplies
Listed on
NSE SME

Quick check

The five things to look at first. Open one for more.

Osel Devices against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

  • Valuation (P/E)20.7 against a typical 26.9: cheaper than most peers (1st = cheapest).7th of 25
  • Sales growth+78% against a typical +21.5% from a year earlier.4th of 18
  • Profit growth+75% against a typical +13.4% from a year earlier.3rd of 16
  • Share price, 3 months−18.7% against a typical −6.4%.18th of 23
  • Size₹ 605 Cr. market value against a typical ₹ 238.1 Cr. (1st = largest).9th of 24

Latest announcements

Exchange filings and their impact on the company.

  • 27 Oct 2026General UpdatesLow impactPositivePrice +0.1% that day
    Clarifies preferential warrants to non-promoter for working capital with 6-month lock-in and Rs 362 valuation.

    Osel Devices clarified its planned preferential issue of convertible warrants to a non-promoter investor. The sole purpose is additional working capital, with a 6-month lock-in on conversion shares. An independent valuer pegged fair value at Rs 362 per share versus around Rs 340 market price. The funds, once approved and converted, should help fund growth and reduce reliance on short-term debt.

    Filing
  • 17 Oct 2026Outcome of Board MeetingLow impactPositivePrice −1.6% on 19 Oct
    Board declares Rs 1 interim dividend and approves 1.7 lakh warrants at Rs 412 to public investors.

    Osel Devices board on October 17, 2026 declared a first interim dividend of Rs 1 per Rs 10 share for FY27 with record date October 24, 2026, with Managing Director Rajendra Ravi Shanker Mishra waiving dividend on his 1.15 crore shares. It also approved issuing up to 1,70,000 convertible warrants at Rs 412 per share to non-promoter public investors, subject to shareholder approval at an EGM on November 12, 2026, raising about Rs 7 crore. The board also appointed Kapil Kohli as Strategic Consultant for distribution and growth.

    Filing

Credit ratings

Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates

Moderate safety, with caution

Rated BBB by CRISIL
BBB
DefaultRiskyModerateSafeVery safe
  • No warnings from the agency.
AgencyCurrent ratingOutlookAs of
CRISILCrisil BBBPositive5 Feb 2026
Credit rating actions
RatingDetails
5 Feb 2026
Reaffirmed
Crisil BBB—CRISIL₹ 48 Cr.
28 Nov 2025
Rating action
Crisil BBB—CRISIL₹ 45 Cr.

Fund raises

QIPs, preferential issues, warrants and rights issues, one row per filing, newest first. Open a row for details. All fund raise updates

Equity fund raises
StageDetails
27 Oct 2026WarrantsShareholders approved———
17 Oct 2026WarrantsBoard approved₹ 7 Cr.₹ 412−17.33%

Research by Minerva Capital Research Solutions

Our research team's work on Osel Devices

Also covered in

Sector note · 2 Apr 2026 · Free
IPO note · 22 Sep 2025 · Free

Board meetings

Results dates and other board meetings. Full calendar

Details
17 Oct 2026Dividend/Fund RaisingTo consider dividend and Fund Raising
29 May 2026Financial ResultsTo consider and approve the financial results for the period ended March 31, 2026
12 Nov 2025Financial ResultsTo consider and approve the financial results for the period ended September 30, 2025
30 Jul 2025Fund RaisingTo consider Fund Raising
26 May 2025Financial ResultsTo consider and approve the financial results for the period ended March 31, 2025
15 May 2025Fund RaisingTo consider Fund Raising

Share price

1Y change −43.86%
0 of 2 filing days came with a big price move
Volume (shares)Price (₹)
Close price

Financials

Consolidated figures in ₹ crore.

Quarterly results
₹ Cr.Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales51828799147146
Expenses42687479122117
Operating Profit91413202529
OPM %17%17%15%20%17%20%
Other Income000002
Interest122246
Depreciation000111
Profit before tax71211182024
Tax %26%35%29%32%26%41%
Net Profit588121514
EPS in Rs26.66.74.977.468.587.95

Growth and returns

Compounded yearly rates over each period.

Compounded Sales Growth
10 Years
—
5 Years
39%
3 Years
53%
TTM
57%
Compounded Profit Growth
10 Years
—
5 Years
85%
3 Years
84%
TTM
46%
Stock Price CAGR
10 Years
—
5 Years
—
3 Years
—
TTM
—
Return on Equity
10 Years
—
5 Years
27%
3 Years
26%
TTM
—

Shareholding

Latest: Jun 2026.

Promoters
64.84%
−6.69 pts in a year
FIIs
0.18%
−1.65 pts in a year
DIIs
3.56%
−1.82 pts in a year
Public
31.42%
+10.16 pts in a year

P/E and EPS over time

Daily P/E and trailing 12-month EPS. EPS updates with each result.

P/E 20.7xEPS (12 months) ₹ 16.51Median P/E 41.4x
P/E (times)EPS (₹)

Prices are delayed and for information only. Nothing on this page is investment advice.